uniQure
QURE
#5100
Rank
NZ$2.76 B
Marketcap
NZ$44.40
Share price
-4.14%
Change (1 day)
57.65%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2025 (TTM): -NZ$0.39 Billion

According to uniQure's latest financial reports the company's current earnings are NZ$15.75 Million. In 2024 the company made an earning of -NZ$0.4 Billion, an increase over its 2023 earnings that were of -NZ$0.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.39 Billion-1.36%
2024 -NZ$0.4 Billion-22.65%
2023 -NZ$0.52 Billion139.01%
2022 -NZ$0.22 Billion-138.54%
2021 NZ$0.55 B-335.29%
2020 -NZ$0.24 Billion13.88%
2019 -NZ$0.21 Billion49.51%
2018 -NZ$0.14 Billion4.55%
2017 -NZ$0.14 Billion12.65%
2016 -NZ$0.12 Billion-9.59%
2015 -NZ$0.13 Billion66.95%
2014 -NZ$77.87 Million30.8%
2013 -NZ$59.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$13.73 B-3,768.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.16 B-4,149.19%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-NZ$0.19 Billion-51.49%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-NZ$0.34 Billion-11.09%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$1.13 B-402.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
-NZ$0.92 Billion 144.63%๐Ÿ‡บ๐Ÿ‡ธ USA